Form 8-K - Current report:
SEC Accession No. 0001193125-22-153609
Filing Date
2022-05-18
Accepted
2022-05-18 08:18:33
Documents
14
Period of Report
2022-05-13
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d319085d8k.htm   iXBRL 8-K 38648
2 EX-99.1 d319085dex991.htm EX-99.1 19440
6 GRAPHIC g319085dsp1.jpg GRAPHIC 5384
  Complete submission text file 0001193125-22-153609.txt   194366

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA amti-20220513.xsd EX-101.SCH 2863
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE amti-20220513_lab.xml EX-101.LAB 17236
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amti-20220513_pre.xml EX-101.PRE 10817
8 EXTRACTED XBRL INSTANCE DOCUMENT d319085d8k_htm.xml XML 3250
Mailing Address 450 EAST JAMIE COURT SOUTH SAN FRANCISCO CA 94080
Business Address 450 EAST JAMIE COURT SOUTH SAN FRANCISCO CA 94080 650-392-0420
Applied Molecular Transport Inc. (Filer) CIK: 0001801777 (see all company filings)

EIN.: 814481426 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39306 | Film No.: 22937121
SIC: 2834 Pharmaceutical Preparations